C. Pease

发表

“An Impediment to Living Life”: Why and How Should We Measure Stiffness in Polymyalgia Rheumatica?

J. Kirwan, S. Mackie, R. Hughes, 2015, PloS one.

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

R. Moots, L. Sharples, P. Emery, 2017, Arthritis & rheumatology.

2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

K. Barraclough, E. Matteson, P. Perel, 2015, Arthritis & rheumatology.

Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips

S. Mackie, C. Pease, 2013, Postgraduate Medical Journal.

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

Claire M. Riddell, R. Moots, D. Symmons, 2019, The Lancet Rheumatology.

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines

R. Moots, D. Isenberg, B. Griffiths, 2016, RMD Open.

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

K. Barraclough, E. Matteson, P. Perel, 2015, Annals of the rheumatic diseases.

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.

K. Chakravarty, D. Scott, D. Lamping, 2007, Arthritis and rheumatism.

Brief Report: Responses to Rituximab Suggest B Cell–Independent Inflammation in Cutaneous Systemic Lupus Erythematosus

P. Emery, C. Pease, Md Yuzaiful Md Yusof, 2015, Arthritis & rheumatology.

Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

H. L. Wright, R. Moots, T. Spector, 2012 .

Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.

J. Scott, C. Pease, R. Butler, 1985, British journal of clinical pharmacology.

A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica

B. Leeb, C. Pease, C. Montecucco, 2005, Annals of the rheumatic diseases.

Comment on: Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors: reply

A. Morgan, S. Mackie, C. Pease, 2012 .

Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study.

W. Thomson, B. Bhakta, W. Ollier, 2008, Rheumatology.

Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.

B. Bhakta, A. Morgan, G. Haugeberg, 2005, The Journal of rheumatology.

THE MYOCARDIUM IN ANKYLOSING SPONDYLITIS A Clinical, Echocardiographic, and Histopathological Study

D. Gibson, C. Pease, P. Revell, 1987, The Lancet.

B cell biomarkers of rituximab responses in systemic lupus erythematosus.

P. Emery, F. Ponchel, C. Pease, 2011, Arthritis and rheumatism.

RS 3 PE syndrome . The relation with HLA B 7

B. Bhakta, L. Punzi, C. Pease, 2000 .

Normal values of laboratory tests in elderly onset psoriatic arthritis

B. Bhakta, C. Pease, 2000 .

Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids

P. Emery, S. Mackie, C. Pease, 2015, Annals of the rheumatic diseases.

Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study.

B. Bhakta, G. Haugeberg, E. Hensor, 2010, Rheumatology.

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy

R. Moots, D. Symmons, D. Isenberg, 2017, Arthritis care & research.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

R. Moots, D. Isenberg, B. Griffiths, 2017, Rheumatology.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

R. Moots, D. Isenberg, B. Griffiths, 2015, Rheumatology.

Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis.

A. Radjenovic, P. Emery, S. Tanner, 2007, Arthritis and rheumatism.

Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors.

B. Bhakta, P. Emery, C. Pease, 1999, Rheumatology.

High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis.

P. Emery, S. Tanner, A. Tan, 2005, Arthritis and rheumatism.

FcgammaRIIIA-158V and rheumatoid arthritis: a confirmation study.

J. Barrett, Jane Worthington, B. Bhakta, 2003, Rheumatology.

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome

P. Emery, C. Pease, Md Yuzaiful Md Yusof, 2022, ACR open rheumatology.

The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome

P. Emery, S. Rauz, C. Pease, 2014, BMC Musculoskeletal Disorders.

Arthritis as the main or only symptom of hepatitis B infection.

C. Pease, A. Keat, 1985, Postgraduate medical journal.

Insufficiency fractures of the distal tibia.

C. Pease, 1994, British journal of rheumatology.

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy

R. Moots, L. Sharples, P. Emery, 2017, Annals of the rheumatic diseases.

Sjögren's syndrome.

C. Pease, S. Sood, R. Anthony, 2000, Clinical otolaryngology and allied sciences.

Anti-La (SS-B): a diagnostic criterion for Sjögren's syndrome?

C. Pease, P. Charles, P. Venables, 1989, Clinical and experimental rheumatology.

The arthropathy of Sjögren's syndrome.

C. Pease, R. Maini, W. Shattles, 1993, British journal of rheumatology.

Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy.

Michael J. Green, P. Emery, C. Pease, 1998, Arthritis & Rheumatism.

LACK OF EVIDENCE FOR GENE CONVERSION IN B27 NEGATIVE ANKYLOSING-SPONDYLITIS

A. McMichael, C. Pease, D. Brewerton, 1987 .

Polymorphonuclear leucocyte motility in men with ankylosing spondylitis.

C. Pease, D. Brewerton, M. Fennell, 1989, Annals of the rheumatic diseases.

leucocyte motility inmen with ankylosing spondylitis

C. Pease, D. Brewerton, M. Fennell, 1989 .

The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy.

Helena Marzo-Ortega, Paul Emery, Philip O'Connor, 2002, Arthritis and rheumatism.

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.

P. Gregersen, C. Wijmenga, J. Barrett, 2015, American journal of human genetics.

A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.

C. Wijmenga, J. Barrett, B. Lie, 2017, American journal of human genetics.

The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study.

M. Bradburn, A. Wailoo, C. Pease, 2016, Health technology assessment.

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome

Anil Wipat, Ian Giles, Jennifer Hallinan, 2015, PloS one.

Meningococcal pericarditis without meningitis.

C. Pease, D. Thompson, A. Howard, 1977, British medical journal.

Late-onset rheumatoid arthritis: is pitting oedema of the hands at onset a good prognostic indicator?

B. Bhakta, C. Pease, 1997, British journal of rheumatology.

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome

R. Moots, D. Isenberg, B. Griffiths, 2011, Annals of the rheumatic diseases.

Polymorphonuclear cell motility, ankylosing spondylitis, and HLA B27.

C. Pease, J. Fordham, H. Currey, 1984, Annals of the rheumatic diseases.

Atlantoaxial subluxation and spinal cord compression in psoriatic arthropathy.

C. Pease, J. Pozo, 1987, Annals of the rheumatic diseases.

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

A. Iagnocco, E. Matteson, R. Marcus, 2012, Annals of the rheumatic diseases.

Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis

Tim F. Rayner, Kenneth G. C. Smith, S. Eyre, 2018, Annals of the rheumatic diseases.

FcγRIIIA‐158V and rheumatoid arthritis: a confirmation study

John D. Isaacs, Michael J. Green, Philip G. Conaghan, 2003 .

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren’s syndrome

R. Moots, D. Isenberg, B. Griffiths, 2019, RMD Open.

Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation

Stephen G. Martin, J. Barrett, A. Morgan, 2015, Arthritis Research & Therapy.

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

A. Iagnocco, H. Kremers, E. Matteson, 2012, Arthritis and rheumatism.

Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: Outcomes of Importance for Patients with PMR

J. Kirwan, L. Simon, S. Mackie, 2014, The Journal of Rheumatology.

Patient-reported Outcomes in Polymyalgia Rheumatica

A. Iagnocco, E. Matteson, R. Marcus, 2012, The Journal of Rheumatology.

Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis

A. Morgan, E. Hensor, S. Mackie, 2012, Annals of the rheumatic diseases.

Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors.

A. Morgan, S. Mackie, C. Pease, 2011, Rheumatology.

Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group

M. Boers, J. Kirwan, C. Hill, 2016, The Journal of Rheumatology.

Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study

Claire M. Riddell, R. Moots, D. Symmons, 2019, Rheumatology International.

R. Moots, D. Isenberg, B. Griffiths, 2013, Annals of the rheumatic diseases.

P. Emery, C. Pease, R. Wakefield, 2003, The Journal of rheumatology.

Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serum

D. Isenberg, P. Emery, J. Tarn, 2013, BMC Musculoskeletal Disorders.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.

R. Moots, D. Isenberg, B. Griffiths, 2018, Swiss medical weekly.

The value of sonography in the detection of bone erosions in patients with rheumatoid arthritis: a comparison with conventional radiography.

John D. Isaacs, Michael J. Green, Philip G. Conaghan, 2000, Arthritis and rheumatism.

Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study

P. Emery, S. Rauz, C. Pease, 2008, Annals of the rheumatic diseases.

Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome

R. Moots, D. Symmons, K. Chakravarty, 2016, Rheumatology International.

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

R. Moots, D. Isenberg, B. Griffiths, 2015, Rheumatology.

An anatomical explanation for good-prognosis rheumatoid arthritis

Michael J. Green, J. Ridgway, P. Emery, 1999, The Lancet.

Serological and immunogenetic markers of extraglandular primary Sjögren's syndrome.

C. Pease, P. Charles, R. Maini, 1993, British journal of rheumatology.

Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy.

Michael J. Green, P. Emery, C. Pease, 1998, Arthritis and rheumatism.

2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

A. Iagnocco, H. Kremers, E. Matteson, 2012, Arthritis and rheumatism.

Clinical, serological, and HLA phenotype subsets in Sjögren's syndrome.

C. Pease, P. Charles, P. Venables, 1989, Clinical and experimental rheumatology.

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

K. Barraclough, E. Matteson, P. Perel, 2015, Annals of the rheumatic diseases.

2015 Recommendations for the Management of Polymyalgia Rheumatica

C. Pease, R. Spiera, J. Hollywood, 2015 .

Rheumatoid arthritis

C. Pease, A. Jackson, Kate Harnden, 2016, British Medical Journal.

Inter-Rater Analysis of Ultrasound and Histological Findings in Patients with Suspected Giant Cell Arteritis

M. Bradburn, A. Wailoo, C. Pease, 2015 .

Corpses and the spread of cholera

P. Emery, C. Pease, F. Cantini, 1999 .

Do rheumatologists think about sex?

C. Pease, Benedict Pease, E. Pease, 2013, Reumatologia clinica.